1197-92-8

Basic information

• Product Name: 1-(2,6,6-trimethylcyclohex-1-en-1-yl)ethanone
• Synonyms: 1-(2,6,6-Trimethyl-1-cyclohexen-1-yl)ethanone; 1-(2,6,6-Trimethylcyclohex-1-en-1-yl)ethanone; ethanone, 1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-
• CAS NO: 1197-92-8
• Molecular Formula: C₁₁H₁₈O
• Molecular Weight: 166.26
• EINECS: 601-634-6
• Mol File: 1197-92-8.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 233.9°C at 760 mmHg
• Flash Point: 88.6°C
• Density: 0.896g/cm³
• Vapor Pressure: 0.0544mmHg at 25°C
• Refractive Index: 1.457
• CAS DataBase Reference: 1-(2,6,6-trimethylcyclohex-1-en-1-yl)ethanone(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2,6,6-trimethylcyclohex-1-en-1-yl)ethanone(1197-92-8)
• EPA Substance Registry System: 1-(2,6,6-trimethylcyclohex-1-en-1-yl)ethanone(1197-92-8)

Safety Data

• Hazardous Substances Data: 1197-92-8(Hazardous Substances Data)

Usage

General Description

1-(2,6,6-trimethylcyclohex-1-en-1-yl)ethanone, also known as isolongifolanone, is a chemical compound with a complex molecular structure. It is a ketone with a cyclohexene ring and three methyl groups attached. Isolongifolanone is commonly found in essential oils of plants such as cypress and hinoki, and is responsible for their distinct odor. 1-(2,6,6-trimethylcyclohex-1-en-1-yl)ethanone is used in the fragrance industry for its woody and earthy aroma, and is often used in perfumes, soaps, and other scented products. In addition, isolongifolanone has also been studied for its potential anti-inflammatory and antimicrobial properties, making it a versatile and useful chemical compound with various applications.

Upstream product

• 54345-61-8 α,2,6,6-tetramethyl-1-cyclohexene-1-methanol 
• 432-25-7 2,6,6-trimethylcyclohex-1-enecarbaldehyde 
• 2816-57-1 2,6-dimethylcyclohexanone 
• 37709-66-3 2,6,6-trimethyl-2-cyclohexenyl methyl ketone 
• 41435-93-2 1-α-acetyl-2-β,6,6-trimethyl-3-cyclohexene 
• 41436-48-0 cis 1-(2,6,6-trimethyl-3-cyclohexen-1-yl)-1-ethanone 
• 41436-48-0 trans 1-(2,6,6-trimethyl-3-cyclohexen-1-yl)-1-ethanone 
• 189633-81-6 2‐iodo‐1,3,3‐trimethylcyclohex‐1‐ene 
• 189633-82-7 2,2,6-trimethyl-cyclohexanone hydrazone 
• 2408-37-9 2,2,6-trimethylcyclohexan-1-one 
• 917-64-6 methyl magnesium iodide 
• 471-90-9 2,6,6-trimethyl-cyclohex-1-enecarboxylic acid 
• 141-79-7 4-methyl-pent-3-en-2-one 
• 25915-53-1 2,6,6-trimethyl-3-cyclohexenyl methyl ketone 

Downstream Products

• 54345-61-8 α,2,6,6-tetramethyl-1-cyclohexene-1-methanol 
• 412035-49-5 hydroxy-(2,6,6-trimethyl-cyclohex-1-enyl)-acetic acid 
• 69578-69-4 1-(2,6,6-trimethyl-cyclohex-1-enyl)-ethanone (6-chloro-pyridazin-3-yl)-hydrazone 
• 163983-04-8 (E)-1-(2,6,6-trimethylcyclohex-1-enyl)-3-(3-furyl)prop-2-en-1-one 
• 334826-81-2 (E)-3-phenyl-1-(2,6,6-trimethylcyclohex-1-enyl)prop-2-en-1-one 
• 1431464-67-3 (E)-4,4-dimethyl-1-(2,6,6-trimethylcyclohex-1-enyl)pent-2-en-1-one 
• 1431464-48-0 3-hydroxy-3-phenyl-1-(2,6,6-trimethylcyclohex-1-enyl)propan-1-one 
• 1431464-50-4 3-hydroxy-4-methyl-1-(2,6,6-trimethylcyclohex-1-enyl)pentan-1-one 
• 1431464-56-0 (E)-1-(2,6,6-trimethylcyclohex-1-enyl)pent-2-en-1-one 
• 1431464-65-1 3-hydroxy-4,4-dimethyl-1-(2,6,6-trimethylcyclohex-1-enyl)pentan-1-one 
• 1431464-69-5 (E)-3-cyclopropyl-1-(2,6,6-trimethylcyclohex-1-enyl)prop-2-en-1-one 
• 35044-68-9 1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-buten-1-one 
• 23726-91-2 beta damascone 
• 41436-46-8 2,6,6-trimethyl-cyclohexa-1,3-dien-1-yl methyl ketone 

Relevant articles and documents

Synthesis of chlorins and bacteriochlorins from cycloaddition reactions with porphyrins

Chlorins and bacteriochlorins are reduced porphyrin-type derivatives displaying characteristic structural, physical, and chemical features. Such features make chlorins and bacteriochlorins key “players” in several fields, and specifically in medicine as p

OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE

Compounds are disclosed that are useful for treating ophthalmic conditions caused by or related to production of toxic visual cycle products that accumulate in the eye, such as dry adult macular degeneration, as well as conditions caused by or related to the misfolding of mutant opsin proteins and/or the mis-localization of opsin proteins. Compositions of these compounds alone or in combination with other therapeutic agents are also described, along with therapeutic methods of using such compounds and/or compositions. Methods of synthesizing such agents are also disclosed.

PROCESS FOR THE ISOMERISATION OF A CYCLOHEXENYL ALKYL OR ALKENYL KETONE

The present invention relates to a process for the carbon-carbon double bond isomerisation of a 2-alkyl-cyclohex-3-enyl alkyl or alkenyl ketone into a mixture comprising the corresponding 2-alkyl-cyclohex-2-enyl ketones and the corresponding 2-alkylene-cy